G 13 7 Pill - yellow oval, 11mm
Pill with imprint G 13 7 is Yellow, Oval and has been identified as Oxcarbazepine 150 mg. It is supplied by Glenmark Generics Inc.
Oxcarbazepine is used in the treatment of Epilepsy; Seizures and belongs to the drug class dibenzazepine anticonvulsants. Risk cannot be ruled out during pregnancy. Oxcarbazepine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for G 13 7
Oxcarbazepine
- Imprint
- G 13 7
- Strength
- 150 mg
- Color
- Yellow
- Size
- 11.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Dibenzazepine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Glenmark Generics Inc.
- Inactive Ingredients
-
silicon dioxide,
ferric oxide yellow,
magnesium stearate,
meglumine,
microcrystalline cellulose,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 68462-0137 | Glenmark Pharmaceuticals Inc. |
| 33261-0684 | Aidarex Pharmacuticals, LLC (repackager) |
Related images for "G 13 7"
More about oxcarbazepine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (383)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: dibenzazepine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Oxcarbazepine drug information
- Oxcarbazepine Extended-Release Tablets
- Oxcarbazepine Tablets
- Oxcarbazepine Oral Suspension
Other brands
Professional resources
- Oxcarbazepine monograph
- Oxcarbazepine (FDA)
- Oxcarbazepine ER Tablets (FDA)
- Oxcarbazepine Suspension (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.